NEW YORK, July 25-Illumina said yesterday that it would provide SNP genotyping services for Britain's Wellcome Trust Sanger Institute to build a haplotype map of a substantial section of the human genome.
Illumina will develop assays for the Sanger SNP collection and use its own technology to genotype those SNPs.
Financial details of the arrangement were not revealed.
The arrangement follows a pilot genotyping study that Illumina conducted for the Sanger Institute in 2001.
Illumina is a San Diego-based public company.
For further details, see the press release.